英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
purehearted查看 purehearted 在百度字典中的解释百度英翻中〔查看〕
purehearted查看 purehearted 在Google字典中的解释Google英翻中〔查看〕
purehearted查看 purehearted 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • XYWAV for Idiopathic Hypersomnia | XYWAV® IH
    XYWAV ® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is a prescription medicine used to treat: the following symptoms in people 7 years of age or older with narcolepsy: sudden onset of weak or paralyzed muscles (cataplexy) excessive daytime sleepiness (EDS)
  • Xywav: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Xywav is a medicine used to treat cataplexy (sudden loss of muscle strength) or to reduce excessive daytime sleepiness (EDS) caused by narcolepsy Xywav is also used in adults to treat idiopathic hypersomnia (IH) , which is an uncommon, chronic sleep disorder that causes daytime sleepiness even after a good night's sleep
  • Xywav for idiopathic hypersomnia: Side effects, cost, and more
    Xywav is also approved to treat excessive daytime sleepiness and cataplexy (sudden muscle weakness) related to narcolepsy Side effects of Xywav when used to treat these narcolepsy-related
  • How Xywav Works, And Other Questions Answered - GoodRx
    In August 2021, the FDA approved Xywav as a treatment option for IH In fact, it’s the only medication that’s FDA-approved for this condition Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy Journal of Clinical Sleep Medicine Schneider, L D , et al (2023)
  • Specialty Guideline Management Xywav - Caremark
    Excessive Daytime Sleepiness (EDS) with Narcolepsy 1-3 Authorization of 12 months may be granted for continued treatment of excessive daytime sleepiness (EDS) with narcolepsy when the member has demonstrated beneficial response to treatment as defined by a decrease in daytime sleepiness with narcolepsy from baseline Idiopathic hypersomnia 1,5
  • Xywav Cuts Symptoms of Idiopathic Hypersomnia | Sleep Review
    Xywav significantly reduced the excessive daytime sleepiness that is a typical hallmark of the sleep disorder idiopathic hypersomnia ESS score of 16 1 (3 6), indicating substantial excessive daytime sleepiness During the Xywav open the best cutoff to differentiate individuals with untreated idiopathic hypersomnia from a control
  • XYWAV for Narcolepsy Idiopathic Hypersomnia | XYWAV®
    XYWAV oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is the only FDA‑approved treatment for cataplexy and or excessive daytime sleepiness in narcolepsy and for idiopathic hypersomnia (IH) in adults
  • Consider XYWAV for Your Idiopathic Hypersomnia Patients | XYWAV HCP
    XYWAV ® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy, and for the treatment of idiopathic hypersomnia (IH) in adults
  • Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing . . .
    Xywav is the only low-sodium oxybate approved by the U S Food and Drug Administration for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy and for adults with idiopathic hypersomnia





中文字典-英文字典  2005-2009